Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04687917 · ClinicalTrials.gov registry record · NA

The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project

A NA study of Substance Use, sponsored by Ohio State University.

Active
Registry status
NA
Development phase
428
Enrollment target
1
Study location

NCT04687917 is a NA study of Substance Use that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 428 participants, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04687917, a NA study of Substance Use, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
428 participants
Enrollment target
1
Study location

Study Summary

An experiment to test the effectiveness of providing monetary bonuses to staff for achieving pre-defined performance targets regarding the implementation of a motivational interviewing-based brief intervention for substance use.

Conditions Studied

Interventions

  • BEHAVIORAL The facilitation, training, feedback, and consultation (FTFC) Strategy
  • BEHAVIORAL The facilitation, training, feedback, consultation, and incentivization (FTFCI) Strategy

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 428 participants
Start Date 2021-01-14
Est. Completion 2026-05-31
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT04687917

The ClinicalTrials.gov registry entry for NCT04687917 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 428 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (66% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which The facilitation, training, feedback, and consultation (FTFC) Strategy is the first listed.

NCT04687917 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT04687917 about?

NCT04687917 is a clinical study titled "The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project". An experiment to test the effectiveness of providing monetary bonuses to staff for achieving pre-defined performance targets regarding the implementation of a motivational interviewing-based brief intervention for substance use.

What is the current status of trial NCT04687917?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 428 participants. The study started on 2021-01-14. Estimated completion is 2026-05-31.

What conditions does trial NCT04687917 study?

This clinical trial studies the following conditions: Substance Use.

What interventions are being tested in trial NCT04687917?

The interventions under investigation include: The facilitation, training, feedback, and consultation (FTFC) Strategy (BEHAVIORAL), The facilitation, training, feedback, consultation, and incentivization (FTFCI) Strategy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04687917?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04687917 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.